Pharmaceutical composition comprising a selective I1 imidazoline receptor agonist and an angiotensin II receptor blocker

Details for Australian Patent Application No. 2004283047 (hide)

Owner Solvay Pharmaceuticals GmbH

Inventors Boedecker, Bernd; Baum, Dominique; Bielenberg, Gerhard-Wilhelm; Thormaehlen, Dirk

Agent Watermark

Pub. Number AU-B-2004283047

PCT Pub. Number WO2005/039639

Priority 03103763.3 10.10.03 EP

Filing date 7 October 2004

Wipo publication date 6 May 2005

Acceptance publication date 17 September 2009

International Classifications

A61K 31/4178 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

4 May 2006 PCT application entered the National Phase

  PCT publication WO2005/039639 Priority application(s): WO2005/039639

17 September 2009 Application Accepted

  Published as AU-B-2004283047

21 January 2010 Standard Patent Sealed

26 July 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee name from Solvay Pharmaceuticals GmbH to Abbott Products GmbH . Address for service in Australia - Watermark Patent and Trade Marks Attorneys Level 2 302 Burwood Road Hawthorn VIC 3122 2005

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283053-In vivo gene therapy of Parkinson's Disease

2004283042-Fungicidal mixtures